Product Information
ENOXAPARIN 30 MG/0.3 ML SYR is a generic product labeled by NorthStar Rx LLC, priced at $9.5038 per ML under NDC 72603016510. Its NADAC has been published 86 times since Dec 13, 2023.
FDA first approved this application on Mar 15, 2023. Its Orange Book therapeutic-equivalence code is AP.
Strength
30 mg/.3mL
Manufacturer
NorthStar Rx LLCNDC
72603016510
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
7/23/2025
Active Ingredients
ENOXAPARIN SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205660FDA Approved
3/15/2023
TE Code
AP
On Market Since
3/15/2023
Pharmacological Classes
Price Statistics
The NADAC for ENOXAPARIN 30 MG/0.3 ML SYR has been published 86 times since Dec 13, 2023, and over the history we have for it it has declined 28.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5038 per ML |
|---|---|
| All-time high | $14.1591 (Jan 10, 2024) |
| All-time low | $7.6552 (Nov 20, 2024) |
| Median price | $11.4486 |
| Average price | $11.2234 |
| Largest weekly change | -30.8% (Nov 20, 2024) |
| Weeks tracked | 86 |
| Tracking since | Dec 13, 2023 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-28.8%
Last surveyed Jul 30, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Enoxaparin Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Low Molecular Weight Heparin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENOXAPARIN 30 MG/0.3 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for ENOXAPARIN 30 MG/0.3 ML SYR, manufactured by NorthStar Rx LLC, is $9.5038 per ML (NDC 72603016510), effective Jul 30, 2025.
How has the price of ENOXAPARIN 30 MG/0.3 ML SYR changed over time?
Over the history we have for it, the NADAC for ENOXAPARIN 30 MG/0.3 ML SYR has declined 28.8%. It has been tracked across 86 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for ENOXAPARIN 30 MG/0.3 ML SYR?
Since Dec 13, 2023, the NADAC for ENOXAPARIN 30 MG/0.3 ML SYR has ranged from a low of $7.6552 (Nov 20, 2024) to a high of $14.1591 (Jan 10, 2024), with a median of $11.4486 per ML.
Are there cheaper alternatives to ENOXAPARIN 30 MG/0.3 ML SYR?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENOXAPARIN 30 MG/0.3 ML SYR, is $9.1268 per ML — about 4% below ENOXAPARIN 30 MG/0.3 ML SYR.
Who manufactures ENOXAPARIN 30 MG/0.3 ML SYR?
ENOXAPARIN 30 MG/0.3 ML SYR (NDC 72603016510) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.